Evidence map›Paper›PMID 37223675›Full record

ArticleFrontiers in oncology2023

Case Report: First longitudinal study of a patient with CALR positive clonal hematopoiesis of indeterminate potential developing into pre-fibrotic myelofibrosis.

Lasse Kjær, Vibe Skov, Morten Kranker Larsen, Tobias Idor Boklund, Morten Andersen, Maria Kefala, Trine A Knudsen, Christina Schjellerup Eickhardt-Dalbøge, Thomas Stiehl, Johanne Gudmand-Høyer and 6 more

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Mathematical modeling ofProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Lasse KjærDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Vibe SkovDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Morten Kranker LarsenDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Tobias Idor BoklundCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Morten AndersenCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Maria KefalaDepartment of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
Trine A KnudsenDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Christina Schjellerup Eickhardt-DalbøgeDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Thomas StiehlCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Johanne Gudmand-HøyerCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Jordan SnyderCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Morten HolmströmNational Center for Cancer Immune Therapy, Copenhagen University Hospital Herlev, Herlev, Denmark.
Mads H AndersenNational Center for Cancer Immune Therapy, Copenhagen University Hospital Herlev, Herlev, Denmark.
Johnny T OttesenCentre for Mathematical Modeling - Human Health and Disease, IMFUFA, Department of Science and Environment, Roskilde University, Roskilde, Denmark.
Christina EllervikDepartment of Data and Data Support, Sorø, Region Zealand, Denmark.
Hans C HasselbalchDepartment of Hematology, Zealand University Hospital, Roskilde, Denmark.
Zealand University Hospital · DKRoskilde University · DKHerlev Hospital · DKRegion Zealand · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Initial diagnosis of overt myeloproliferative neoplasms (MPNs) represents the juncture during clonal evolution when symptoms or complications prompt an afflicted individual to seek medical attention. In 30-40% of the MPN subgroups essential thrombocythemia (ET) and myelofibrosis (MF), somatic mutations in the calreticulin gene (

Indexed as

CALRcase reportclonal hematopoiesisMPNmyelofibrosis

Identifiers

PMID37223675
PMCPMC10200979
OpenAlexW4375866900

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.